(2S)-2-((tert-Butoxycarbonyl)amino)-2-(3-hydroxyadamantan-1-yl)acetic acid | CAS:361442-00-4

We serve (2S)-2-((tert-Butoxycarbonyl)amino)-2-(3-hydroxyadamantan-1-yl)acetic acid CAS:361442-00-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
 (2S)-2-((tert-Butoxycarbonyl)amino)-2-(3-hydroxyadamantan-1-yl)acetic acid

Chemical Name: (2S)-2-((tert-Butoxycarbonyl)amino)-2-(3-hydroxyadamantan-1-yl)acetic acid
CAS.NO:361442-00-4
Synonyms:
BOC-L-SERINE T-BUTYLESTER
Boc-3-Hydroxy-1-adamantyl-D-glycine
Boc-L-Serine tert.butyl ester
(S)-N-Boc-3-hydroxyadamantylglycine
Boc-Ser-Otbu

Molecular Formula:C17H27NO5
Molecular Weight: 325.40000

Physical and Chemical Properties:
Density:1.296g/cm3
Boiling point: 497.253ºC at 760 mmHg
Melting point: /
Flash point:225.4±23.2 °C
Refractive index: 1.540

Specification:
Appearance: White to off-white crystalline powder
Purity:≥98%
Water:≤0.5%
Residue on ignition:≤0.5%
Loss on drying:≤0.5%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Saxagliptin CAS:361442-04-8
Intermediates of Saxagliptin hydrochloride CAS:709031-78-7



Contact us for information like (2S)-2-((tert-Butoxycarbonyl)amino)-2-(3-hydroxyadamantan-1-yl)acetic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Boc-Ser-Otbu physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Boc-L-Serine tert.butyl ester Use and application,Boc-Ser-Otbu technical grade,usp/ep/jp grade.


Related News: Under the sub-licensing agreement, Mankind will market the drug under its own trademark while Glenmark will manufacture and supply it to the drug firm.4-(Difluoromethoxy)aniline manufacturer On the basis of achieving low-cost and high-quality processes, production capacity will become the core driving force for API companies to break through sales bottlenecks.5-nitrocyclohexene-1-carbaldehyde supplier On the basis of achieving low-cost and high-quality processes, production capacity will become the core driving force for API companies to break through sales bottlenecks.9-(3-bromophenyl)-10-phenylanthracene vendor The on-body wear is similar to that of an insulin pump. Unlike insulin pump therapy, however, the investigational system is designed such that users enter only their body weight for the iLet to initialize therapy.However, in 2018, the World Health Organization (WHO) gave its long-awaited nod to include TCM in its influential book classifying thousands of diseases — its first-ever official endorsement of the ancient practice.